India-based medical device manufacturer BPL Medical Technologies has announced the acquisition of Yozma BMtech Co., Ltd., a South Korea–based firm specializing in bone mineral density (BMD) diagnostic technologies, in a strategic move to expand its preventive healthcare and imaging diagnostics portfolio..

总部位于印度的医疗器械制造商BPL Medical Technologies宣布收购韩国公司Yozma BMtech Co., Ltd.，这是一家专注于骨密度（BMD）诊断技术的企业。此举旨在扩大其预防医疗和影像诊断产品组合。

Following the acquisition, BPL Medical Technologies has introduced BMtech’s advanced bone mineral density measuring systems in key markets including India and Dubai. The systems are designed to support early screening and monitoring of osteoporosis and other bone-related disorders, addressing the growing demand for preventive diagnostics amid ageing populations and lifestyle-related health risks..

收购完成后，BPL医疗技术公司已在包括印度和迪拜在内的关键市场推出了BMtech先进的骨密度测量系统。这些系统旨在支持对骨质疏松症和其他骨骼相关疾病的早期筛查和监测，满足了在人口老龄化和生活方式相关健康风险日益增加的情况下对预防性诊断的不断增长的需求。

The newly introduced diagnostic solutions incorporate high-speed scanning, high-resolution imaging, and low-radiation exposure, enhancing both patient safety and diagnostic accuracy. Built using fan-beam technology with multi-channel detectors, the systems can measure bone density across multiple anatomical sites and support whole-body densitometry and body composition analysis in select models..

新推出的诊断解决方案结合了高速扫描、高分辨率成像和低辐射暴露，提高了患者的安全性和诊断的准确性。该系统采用扇形束技术与多通道探测器构建，能够测量多个解剖部位的骨密度，并在部分型号中支持全身骨密度和身体成分分析。

Industry experts note that the integration of BMtech’s technology strengthens BPL’s capabilities in preventive diagnostics, musculoskeletal imaging, and women’s health, particularly in the early detection and management of osteoporosis among post-menopausal women. The compact design of the systems also enables installation in hospitals and diagnostic centres with limited space, expanding accessibility to bone health screening services..

行业专家指出，BMtech技术的整合增强了BPL在预防诊断、肌肉骨骼成像和女性健康方面的能力，特别是在绝经后妇女骨质疏松症的早期检测和管理方面。系统的紧凑设计还能够安装在空间有限的医院和诊断中心，扩大了骨骼健康筛查服务的可及性。

Commenting on the acquisition, Shravan Subramanyam, Managing Director of BPL Medical Technologies, stated that strengthening bone health diagnostics is a critical step toward improving preventive healthcare outcomes.

BPL医疗技术公司的董事总经理Shravan Subramanyam在谈及此次收购时表示，加强骨骼健康诊断是改善预防性医疗保健结果的关键一步。

The acquisition is expected to accelerate innovation in imaging and diagnostics by combining BMtech’s specialized bone density technology with BPL’s manufacturing capabilities, distribution network, and clinical expertise. The move also supports the company’s broader strategy of expanding its global footprint and enhancing access to advanced diagnostic technologies in emerging healthcare markets..

通过将BMtech专业的骨密度技术与BPL的制造能力、分销网络和临床专业知识相结合，此次收购预计将加速影像和诊断领域的创新。此举还支持了公司扩大全球足迹的更广泛战略，并增强新兴医疗市场对先进诊断技术的可及性。

Healthcare analysts believe the development reflects the increasing emphasis on preventive diagnostics and early disease detection, areas expected to see significant growth as healthcare systems worldwide shift toward proactive and data-driven care models.

医疗保健分析师认为，这一发展反映了对预防性诊断和早期疾病检测的日益重视，随着全球医疗系统向主动和数据驱动的护理模式转变，这些领域预计将出现显著增长。